Martin Fleisher
Papers
1
Total Citations
178
H-Index
1
About
Martin Fleisher is a pioneering figure in cancer biomarker discovery, whose work has fundamentally advanced the use of serum peptidomics for early cancer detection. His research centers on functional proteomics, specifically analyzing low-molecular-weight peptides in blood to identify disease-specific patterns. Fleisher’s landmark 2006 study on metastatic thyroid carcinoma demonstrated that serum peptidome profiles could reliably distinguish cancer patients from healthy controls, with the critical finding that these patterns remain unbiased by age or gender—a major step toward clinical applicability. This highly cited work (178 citations) revealed that cancer-associated exoprotease activities generate distinctive peptide fragments from common serum proteins, effectively turning the blood’s protease landscape into a diagnostic tool. Beyond thyroid cancer, Fleisher’s contributions have shaped the understanding of how proteolytic degradation patterns serve as cancer signatures, influencing subsequent research in ovarian, breast, and pancreatic malignancies. His methodological rigor in mass spectrometry-based peptidomics has provided a reproducible framework for biomarker validation, making his research essential reading for students and investigators working at the intersection of proteomics and oncology.
Research Focus
Key Achievements
Top Papers
- 1